ACP Journal Club19 August 2008Review: Limited evidence suggests that statins are safe in patients with liver diseaseEric R. Bates, MDEric R. Bates, MDUniversity of Michigan, Ann Arbor, Michigan, USA (E.R.B.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-149-4-200808190-02012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationOnofrei MD, Butler KL, Fuke DC, Miller HB. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy. 2008;28:522-9. https://pubmed.ncbi.nlm.nih.gov/18363535Clinical Impact RatingsGIM/FP/GP: Cardiology: Endocrinology: Gastroenterology: Reference1 McKenney JM, Davidson MH, Jacobson TA, Guyton JR, National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97:89C-94C. [PMID: 16581336] Google Scholar Author, Article, and Disclosure InformationAffiliations: University of Michigan, Ann Arbor, Michigan, USA (E.R.B.)This article was published at Annals.org on 5 August 2008. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 19 August 2008Volume 149, Issue 4Page: JC2-12KeywordsAminotransferasesLiver diseasesLiver function testsSafetySafety studiesStatinsTransferases ePublished: 19 August 2008 Issue Published: 19 August 2008 CopyrightCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...